Last mentioned: Feb 25, 2026
LifeStance Health Group and Dole have released their fourth-quarter results, providing a roadmap for 2026 that highlights divergent paths in the healthcare and consumer staples sectors. While LifeStance focuses on scaling its mental health platform, Dole navigates a complex global supply chain to maintain its fresh produce leadership.
This page surfaces every story mentioning LifeStance Health Group across our finance coverage. We track each entity's appearance over time so readers can trace how the narrative evolves — which developments are isolated incidents, which build into longer arcs, and which reframe how operators in the space think about the entity. Story selection uses the same multi-source verification gate applied across the rest of our coverage.
Read our editorial methodology for how we identify, deduplicate, and score entity references. Our glossary defines the technical terms used across stories on this page, and our trends index contextualizes individual developments against the longer-running finance beat. Cross-entity comparisons live on our compare view.
| What you see | What it tells you |
|---|---|
| Story count | Number of distinct stories where LifeStance Health Group was a primary or referenced actor. |
| Recency clustering | Whether mentions are concentrated in a recent window (a news cycle) or distributed (a sustained arc). |
| Sentiment distribution | Aggregate sentiment of the stories mentioning this entity, weighted by impact score. |
| Cross-niche links | When the same entity surfaces in our sibling networks, we link to those views to enrich context. |